18 research outputs found
Recommended from our members
Shielding gas composition and electrode geometry influence on arc properties
The effects of welding electrode geometry and of shielding gas composition using pure argon, argon-helium mixtures, and an argon-hydrogen mixture on welding arc properties, particularly acr temperature distribution was studied. Plasma diagnostic techniques were used to measure the arc properties presented. A computer-controlled emission spectroscopy system comprised of an Optical Multichannel Analyzer (OMA) interfaced to 0.3-m monochromator was used to make temperature and composition measurements. Electrode tip geometry was found to have a somewhat restricted influence on arc temperature distribution. The addition of significant amounts of helium to argon shielding gas causes a gas tungsten arc to be a broader, more isothermal, heat source than an arc shielded with pure argon. Blunt electrode tip geometries, compared to sharp ones, tend to cause flatter temperature distributions in pure argon but have temperature distributions similar to sharp electrode tips in moderate to high helium environments. Thermophysical properties of the shielding gas constituents appear to have greater influence on fusion zone profile than does arc temperature. However, refined heat transfer models of the future will require arc temperature distributions as a function of essential welding variables since these models will use properties which are strongly temperature dependent
Recommended from our members
Fiscal Year 1994
The purpose of these experiments was to study the dissolution, retention, volatilization, and trapping of transuranic radionuclide elements (TRUs), mixed fission and activation products, and high vapor pressure metals (HVPMS) during processing in a high temperature arc furnace. In all cases, surrogate elements (lanthanides) were used in place of radioactive ones. The experiments were conducted utilizing a small DC arc melter developed at the Idaho National Engineering Laboratory (INEL) Research Center (IRC). The small arc melter was originally developed in 1992 and has been used previously for waste form studies of iron enriched basalt (IEB) and IEB with zirconium and titanium additions (IEB4). Section 3 contains a description of the small arc melter and its operational capabilities are discussed in Chapter 4. The remainder of the document describes each testing program and then discusses results and findings
The Earth: Plasma Sources, Losses, and Transport Processes
This paper reviews the state of knowledge concerning the source of magnetospheric plasma at Earth. Source of plasma, its acceleration and transport throughout the system, its consequences on system dynamics, and its loss are all discussed. Both observational and modeling advances since the last time this subject was covered in detail (Hultqvist et al., Magnetospheric Plasma Sources and Losses, 1999) are addressed
Recommended from our members
Plasma diagnostics approach to welding heat source/molten pool interaction
Plasma diagnostic techniques show that weld fusion zone profile and loss of metal vapors from the molten pool are strongly dependent on both the intensity and distribution of the heat source. These plasma properties, are functions of cathode vertex angle and thermal conductivity of the shielding gas, especially near the anode
The gas-phase bis-uranyl nitrate complex [(UO2)2(NO3)5]-: Infrared spectrum and structure
The gas-phase bis-uranyl nitrate complex [(UO2)2(NO3)5]-: Infrared spectrum and structure
The infrared spectrum of the bis-uranyl nitrate complex [(UO2)2(NO3)5]− was measured in the gas phase using multiple photon dissociation (IRMPD). Intense absorptions corresponding to the nitrate symmetric and asymmetric vibrations, and the uranyl asymmetric vibration were observed. The nitrate ν3 vibrations indicate the presence of nitrate in a bridging configuration bound to both uranyl cations, and probably two distinct pendant nitrates in the complex. The coordination environment of the nitrate ligands and the uranyl cations were compared to those in the mono-uranyl complex. Overall, the uranyl cation is more loosely coordinated in the bis-uranyl complex [(UO2)2(NO3)5]− compared to the mono-complex [UO2(NO3)3]−, as indicated by a higher O-U-O asymmetric stretching (ν3) frequency. However, the pendant nitrate ligands are more strongly bound in the bis-complex than they are in the mono-uranyl complex, as indicated by the ν3 frequencies of the pendant nitrate, which are split into nitrosyl and O-N-O vibrations as a result of bidentate coordination. These phenomena are consistent with lower electron density donation per uranyl by the nitrate bridging two uranyl centers compared to that of a pendant nitrate in the mono-uranyl complex. The lowest energy structure predicted by density functional theory (B3LYP functional) calculations was one in which the two uranyl molecules bridged by a single nitrate coordinated in a bis-bidentate fashion. Each uranyl molecule was coordinated by two pendant nitrate ligands. The corresponding vibrational spectrum was in excellent agreement with the IRMPD measurement, confirming the structural assignment
Complete genome sequence and the expression pattern of plasmids of the model ethanologen Zymomonas mobilis ZM4 and its xylose-utilizing derivatives 8b and 2032
Background: Zymomonas mobilis is a natural ethanologen being developed and deployed as an industrial biofuel producer. To date, eight Z. mobilis strains have been completely sequenced and found to contain 2-8 native plasmids. However, systematic verification of predicted Z. mobilis plasmid genes and their contribution to cell fitness has not been hitherto addressed. Moreover, the precise number and identities of plasmids in Z. mobilis model strain ZM4 have been unclear. The lack of functional information about plasmid genes in ZM4 impedes ongoing studies for this model biofuel-producing strain. Results: In this study, we determined the complete chromosome and plasmid sequences of ZM4 and its engineered xylose-utilizing derivatives 2032 and 8b. Compared to previously published and revised ZM4 chromosome sequences, the ZM4 chromosome sequence reported here contains 65 nucleotide sequence variations as well as a 2400-bp insertion. Four plasmids were identified in all three strains, with 150 plasmid genes predicted in strain ZM4 and 2032, and 153 plasmid genes predicted in strain 8b due to the insertion of heterologous DNA for expanded substrate utilization. Plasmid genes were then annotated using Blast2GO, InterProScan, and systems biology data analyses, and most genes were found to have apparent orthologs in other organisms or identifiable conserved domains. To verify plasmid gene prediction, RNA-Seq was used to map transcripts and also compare relative gene expression under various growth conditions, including anaerobic and aerobic conditions, or growth in different concentrations of biomass hydrolysates. Overall, plasmid genes were more responsive to varying hydrolysate concentrations than to oxygen availability. Additionally, our results indicated that although all plasmids were present in low copy number (about 1-2 per cell), the copy number of some plasmids varied under specific growth conditions or due to heterologous gene insertion. Conclusions: The complete genome of ZM4 and two xylose-utilizing derivatives is reported in this study, with an emphasis on identifying and characterizing plasmid genes. Plasmid gene annotation, validation, expression levels at growth conditions of interest, and contribution to host fitness are reported for the first time. © 2018 The Author(s)
Dual Glutathione-S-Transferase-θ1 and -μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Glutamatergic dysfunction is implicated in schizophrenia pathoaetiology, but this may vary in extent between patients. It is unclear whether inter-individual variability in glutamate is greater in schizophrenia than the general population. We conducted meta-analyses to assess (1) variability of glutamate measures in patients relative to controls (log coefficient of variation ratio: CVR); (2) standardised mean differences (SMD) using Hedges g; (3) modal distribution of individual-level glutamate data (Hartigan's unimodality dip test). MEDLINE and EMBASE databases were searched from inception to September 2022 for proton magnetic resonance spectroscopy (1H-MRS) studies reporting glutamate, glutamine or Glx in schizophrenia. 123 studies reporting on 8256 patients and 7532 controls were included. Compared with controls, patients demonstrated greater variability in glutamatergic metabolites in the medial frontal cortex (MFC, glutamate: CVR = 0.15, p < 0.001; glutamine: CVR = 0.15, p = 0.003; Glx: CVR = 0.11, p = 0.002), dorsolateral prefrontal cortex (glutamine: CVR = 0.14, p = 0.05; Glx: CVR = 0.25, p < 0.001) and thalamus (glutamate: CVR = 0.16, p = 0.008; Glx: CVR = 0.19, p = 0.008). Studies in younger, more symptomatic patients were associated with greater variability in the basal ganglia (BG glutamate with age: z = -0.03, p = 0.003, symptoms: z = 0.007, p = 0.02) and temporal lobe (glutamate with age: z = -0.03, p = 0.02), while studies with older, more symptomatic patients associated with greater variability in MFC (glutamate with age: z = 0.01, p = 0.02, glutamine with symptoms: z = 0.01, p = 0.02). For individual patient data, most studies showed a unimodal distribution of glutamatergic metabolites. Meta-analysis of mean differences found lower MFC glutamate (g = -0.15, p = 0.03), higher thalamic glutamine (g = 0.53, p < 0.001) and higher BG Glx in patients relative to controls (g = 0.28, p < 0.001). Proportion of males was negatively associated with MFC glutamate (z = -0.02, p < 0.001) and frontal white matter Glx (z = -0.03, p = 0.02) in patients relative to controls. Patient PANSS total score was positively associated with glutamate SMD in BG (z = 0.01, p = 0.01) and temporal lobe (z = 0.05, p = 0.008). Further research into the mechanisms underlying greater glutamatergic metabolite variability in schizophrenia and their clinical consequences may inform the identification of patient subgroups for future treatment strategies